Zebrafish offer the potential for a primary screen to identify a wide variety of potential anticonvulsants

This publication has 20 references indexed in Scilit:

• Development of aDrosophilaseizure model forin vivohigh‐throughput drug screening
  European Journal of Neuroscience, 2006
• The zebrafish as a model system for assessing the reinforcing properties of drugs of abuse
  Methods, 2006
• In vivo drug discovery in the zebrafish
  Nature Reviews Drug Discovery, 2005
• Zebrafish as a pharmacological tool: the how, why and when
  Current Opinion in Pharmacology, 2004
• Zebrafish: A new model on the pharmaceutical catwalk
  BioEssays, 2003
• Morpholino phosphorodiamidate oligonucleotides in zebrafish: A recipe for functional genomics?
  Briefings in Functional Genomics and Proteomics, 2002
• An on-line database for zebrafish development and genetics research
  Seminars in Cell & Developmental Biology, 1997
• Stages of embryonic development of the zebrafish
  Developmental Dynamics, 1995
• Animal models of the epilepsies
  Brain Research Reviews, 1989
• Landmark article Sept 17, 1938: Sodium diphenyl hydantoinate in the treatment of convulsive disorders. By H. Houston Merritt and Tracy J. Putnam
  JAMA, 1984